| Names | |
|---|---|
| IUPAC name 3β,14-Dihydroxy-5β-bufa-20,22-dienolide | |
| Systematic IUPAC name 4-[(1R,3aS,3bR,5aR,7S,9aS,9bS,11aR)-3a,7-Dihydroxy-9a,11a-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-1-yl]-2H-pyran-2-one | |
| Identifiers | |
3D model (JSmol) | |
| ChEBI | |
| ChEMBL | |
| ChemSpider | |
| ECHA InfoCard | 100.150.073 |
PubChem CID | |
| UNII | |
CompTox Dashboard (EPA) | |
| |
| |
| Properties | |
| C24H34O4 | |
| Molar mass | 386.532 g·mol−1 |
| Hazards | |
| GHS labelling: | |
| | |
| Danger | |
| H300 | |
| P264, P270, P301+P310, P321, P330, P405, P501 | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
Bufalin is a cardiotonic steroid toxin [1] originally isolated from Chinese toad venom, which is a component of some traditional Chinese medicines. [2] [3]
Bufalin has in vitro antitumor effects against various malignant cell lines, including hepatocellular [4] and lung carcinoma. [5] However, as with other bufadienolides, its potential use is hampered by its cardiotoxicity. [6]